Nextech Invest AG
CIK
1911010
Location
Zurich, V8
Portfolio Value
Small
$561,053,081
Diversification
Highly concentrated
Filing Date
Global Rank
#2,279
/ 8,036
▼ 217
Top Industry
Biotechnology
100.0%
3Y Alpha vs SPY
+26.7%
Period ended 1 year ago
Filed Feb 14, 2025 · 1y
13 quarters · since Dec 2021
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+221.2%
SPY
+76.3%
Annualised alpha
+26.7%
Max drawdown
−52.8%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
13 positions · as of Dec 31, 2024 · Δ vs Sep 30, 2024Top Position
59.3%
+14.7 pts
Top 5
84.8%
+4.8 pts
Top 10
96.8%
+1.9 pts
HHI
3,736
Highly concentrated+1,327
Portfolio Trend
13 quarters · across all stocks
Sector Breakdown
As of Dec 31, 2024| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $561,053,081 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| RVMD | Revolution Medicines, Inc. | +1,304,347 | 7,601,087 | $332,471,545 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals, Inc. | −176,300 | 936,729 | $9,882,490 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
13 positions ·
$561,053,081 total
· as of Dec 31, 2024
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Added | 7,601,087 | $332,471,545 | 59.26% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
Held | 4,055,861 | $56,376,467 | 10.05% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Held | 5,285,714 | $42,655,711 | 7.60% | |
| ARVN |
Arvinas, Inc.
Healthcare
|
Held | 1,408,394 | $26,998,912 | 4.81% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Held | 5,533,980 | $17,099,998 | 3.05% | |
| ZYME |
Zymeworks Inc.
Healthcare
|
Held | 1,113,946 | $16,308,169 | 2.91% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
Held | 3,846,409 | $15,847,205 | 2.82% | |
| CGEM |
Cullinan Therapeutics, Inc.
Healthcare
|
Held | 1,141,145 | $13,899,146 | 2.48% | |
| ALMS |
Alumis Inc.
Healthcare
|
Held | 1,476,998 | $11,609,204 | 2.07% | |
| SPRY |
ARS Pharmaceuticals, Inc.
Healthcare
|
Reduced | 936,729 | $9,882,490 | 1.76% | |
| CNTX |
Context Therapeutics Inc.
Healthcare
|
Held | 7,419,355 | $7,790,322 | 1.39% | |
| SLN |
Silence Therapeutics plc
Healthcare
|
Held | 952,400 | $6,552,512 | 1.17% | |
| BOLD |
Boundless Bio, Inc.
Healthcare
|
Held | 1,228,069 | $3,561,400 | 0.63% |